In contrast, ligand activation of PPARβ/δ inhibits proliferation of vascular smooth muscle cells (VSMCs) [90,91,92], HaCaT keratinocytes [93], as well as breast cancer cell lines [94] and PPARβ/δ deletion promotes cancer EC proliferation [23]. Here, PPARD is linked to breast carcinoma.